Short answer
USANA HEALTH SCIENCES INC (USNA) filed its Q2 2026 10-Q quarterly report on May 12, 2026 for the quarter ended Apr 4, 2026. Quarterly revenue was $250M (up 0.3% year over year) with net income of $8M.
Q2 2026 key financials · XBRL
- Revenue
- $250M
- +0.3% YoY
- Net income
- $8M
- −20.1% YoY
- Operating margin
- 5.5%
- Gross margin
- 76.2%
- EPS (diluted)
- $0.41
- −16.3% YoY
Source: XBRL data from the USANA HEALTH SCIENCES INC (USNA) Q2 2026 10-Q on SEC EDGAR. USD.
USANA HEALTH SCIENCES INC Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $250.2M, up 0.3% YoY from $249.5M
- Rise strongest segment: $13.7M revenue, up 740.7% YoY; Core Nutritional weakest, down 3.0% to $204.4M
- Gross margin 76.2% vs 79.0% YoY; operating margin 5.5% vs 6.3%
- Cash $162.8M vs $158.4M; operating cash flow $9.8M vs $15.5M YoY
- Active Customers down 12.0% to 404,000; Hiya subscribers down to 186,000 from 224,000
Risk Factors
- No material changes to risk factors identified in the 2025 Form 10-K
- Repurchase authorization $34.0 million as of April 4, 2026
- No common-stock purchases under the repurchase plan during the quarter
- No directors or officers adopted, modified, or terminated Rule 10b5-1 arrangements
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other USANA HEALTH SCIENCES INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.